216303412.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

216303412.Pdf Published Online: 31 July, 2006 | Supp Info: http://doi.org/10.1083/jcb.200603146 JCB: ARTICLE Downloaded from jcb.rupress.org on April 19, 2019 Role of TIF1α as a modulator of embryonic transcription in the mouse zygote Maria Elena Torres-Padilla and Magdalena Zernicka-Goetz The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QR, England, UK he fi rst events of the development of any embryo into zygotes, most of the embryos arrest their develop- are under maternal control until the zygotic ge- ment at the 2–4-cell stage transition. The ablation of T nome becomes activated. In the mouse embryo, TIF1α leads to mislocalization of RNA polymerase II and the major wave of transcription activation occurs at the the chromatin remodelers SNF2H and BRG-1. Using a 2-cell stage, but transcription starts already at the zy- chromatin immunoprecipitation cloning approach, we gote (1-cell) stage. Very little is known about the mole- identify genes that are regulated by TIF1α in the zygote cules involved in this process. We show that the and fi nd that transcription of these genes is misregulated transcription intermediary factor 1 α (TIF1α) is involved upon TIF1α ablation. We further show that the expres- in modulating gene expression during the fi rst wave of sion of some of these genes is dependent on SNF2H and transcription activation. At the onset of genome activa- that RNAi for SNF2H compromises development, sug- tion, TIF1α translocates from the cytoplasm into the pro- gesting that TIF1α mediates activation of gene expres- nuclei to sites of active transcription. These sites are sion in the zygote via SNF2H. These studies indicate that enriched with the chromatin remodelers BRG-1 and TIF1α is a factor that modulates the expression of a set SNF2H. When we ablate TIF1α through either RNA in- of genes during the fi rst wave of genome activation in terference (RNAi) or microinjection of specifi c antibodies the mouse embryo. Introduction After germinal vesicle (GV) breakdown, the fully grown oo- of the zygote and represents 40% of the transcriptional levels cyte is transcriptionally silent (Bachvarova, 1985). After fer- observed at the 2-cell stage (Aoki et al., 1997; Bouniol-Baly tilization, chromatin remodeling has been proposed to provide et al., 1997; Hamatani et al., 2004). a window of opportunity for transcription factors to bind the Transcription intermediary factor (TIF) 1 α (Trim24) regulatory sequences of genes that must be activated for de- was fi rst identifi ed as a transcriptional regulator of nuclear velopment to proceed (Ma et al., 2001; Morgan et al., 2005). receptors and has been shown to interact with numerous pro- THE JOURNAL OF CELL BIOLOGY Concomitantly, a transcriptionally repressed state would be teins involved in chromatin structure (Le Douarin et al., 1995, necessary to prevent promiscuous gene expression as a re- 1996; Fraser et al., 1998; Nielsen et al., 1999; Remboutsika sult of a “general permissiveness” of the genome (for reviews et al., 2002; Germain-Desprez et al., 2003). TIF1α is one of see Thompson et al., 1998; Schultz, 2002). In the mouse, two four TIFs described in mammals that belong to the tripar- phases of transcriptional activation lead to the transition from tite motif superfamily of proteins (Le Douarin et al., 1995, maternal to zygotic control of gene expression (Schultz, 2002). 1996; Venturini et al., 1999; Khetchoumian et al., 2004). The major and most studied wave of activation is the sec- TIF1β (Trim28) is required for the proper specifi cation of the ond one, which begins at the late 2-cell stage. However, less anteroposterior axis in the mouse (Cammas et al., 2000). is known about the fi rst wave, which occurs in the pronuclei Little is known about the biological function of TIF1α, and its expression pattern is only known at late stages of post- implantation development (Niederreither et al., 1999). Here, Correspondence to Magdalena Zernicka-Goetz: [email protected] α Abbreviations used in this paper: BRG-1, Brahma-related gene 1; BrUTP, 5-bromo we have characterized the role of TIF1 in early mouse UTP; ChIP, chromatin immunoprecipitation; dsRNA, double-stranded RNA; embryogenesis. We show that TIF1α acts as a modulator of GV, germinal vesicle; hCG, human chorionic gonadotrophin; HP1, heterochro- the transcriptional state of a particular set of genes during the matin protein 1; ICM, inner cell mass; NLB, nucleolar-like body; TIF, transcription intermediary factor. fi rst wave of genome activation and that ablation of TIF1α The online version of this article contains supplemental material. compromises development. © The Rockefeller University Press $8.00 The Journal of Cell Biology, Vol. 174, No. 3, July 31, 2006 329–338 http://www.jcb.org/cgi/doi/10.1083/jcb.200603146 JCB 329 Results At the GV stage, TIF1α protein was detected in the oocyte cytoplasm (Fig. 1 c). Shortly after fertilization, TIF1α remained TIF1 expression is gradually restricted predominantly cytoplasmic, but it moved to both pronuclei at to the inner cells of cleavage stage embryos, the mid and late zygote stages. TIF1α became localized to dis- and the protein translocates into the crete regions associated with the nucleolar-like bodies (NLBs), pronucleus at the onset of genome activation which are a compact mass of DNA surrounded by a perinu- We fi rst analyzed the expression pattern of Tif1α in oocytes and cleolar chromatin ring that cause the characteristic pattern of throughout preimplantation development by in situ hybridiza- DNA staining visible at these stages (Fig. 1, c and d; Kopecny tion and RT-PCR. Tif1α was expressed from the GV stage oo- et al., 1995). This distribution was observed in both male and cyte to the blastocyst (Fig. 1, a and b). Initially, Tif1α transcripts female pronuclei, although in some cases (11 of 32 zygotes were present in all blastomeres, but as development progressed, analyzed), TIF1α was only seen in the male pronucleus, most Tif1α transcripts became restricted to the inner cells of the em- likely refl ecting the fact that the male pronucleus undergoes bryo (Fig. 1 a). This became evident at the 16-cell stage, and transcriptional activation earlier (Bouniol et al., 1995). TIF1α when the blastocyst formed, Tif1α expression was restricted to remained associated with NLBs through the 2-cell stage and, al- the inner cell mass (ICM). though less prominent, throughout the 4-cell stage. This pattern Figure 1. TIF1 expression becomes gradually restricted in the early embryo, and the protein translocates into the pronucleus around the onset of genome activation. (a) In situ hybridization for TIF1α of 2-cell (i), 5–8-cell (ii), 16-cell (iii), and 32-cell embryos (iv) and expanding (v) and late (vi) blastocyst. The insets within panels i and ii show em- bryos at the 2- and 8-cell stages, respectively, processed with the sense probe. Expression of TIF1α is enriched in the inner cells of the mouse embryo from the 16-cell stage onward and is restricted to the ICM of the blastocyst. Shown are representative embryos of at least 20 embryos and two independent experiments for each stage. (b) RT-PCR analysis for TIF1α of mouse oocytes and embryos at the specifi ed stages. GVBD/MI, GV breakdown and meta- phase I arrested oocytes; E, embryonic day. At least fi ve embryos per stage were analyzed. Note that the mRNA levels of actin are known to decline after oocyte maturation (Temeles et al., 1994) and should only be considered as control of amplifi cation and not for quantifi cation purposes. (c) Immunolocalization of TIF1α protein (red) in GV oocyte and early, mid, and late zygote at 2- and 4-cell stages. All samples were analyzed under comparable confocal imaging settings. In all panels, DNA was stained with TOTO-3 (blue). Shown are representative embryos of at least 20 embryos analyzed per stage from at least three independent experiments. Below the merge panel, the red channel (TIF1α) is shown as grayscale. (d) Higher magni- fi cations of the pronuclei of mid and late zygotes and the nuclei of 2- and 4-cell stage embryos. Arrows indicate the dense accumulation of TIF1α. Albeit weaker, association of TIF1α with NLBs persists in the 2- and 4-cell stage embryos. The pronuclei shown in higher magnifi cation are male. (e) TIF1β (red) exhibits a diffuse pattern of local- ization in the two pronuclei of the mouse zygotes. The right panel is a higher magnifi cation of the region (male pronucleus) marked with the white square in the left panel. DNA is shown in blue. 330 JCB • VOLUME 174 • NUMBER 3 • 2006 of localization in dense spots was specifi c for TIF1α because BRG-1 (Fig. 2 b, middle and bottom). Moreover, similar to the TIF1β was uniformly distributed throughout the nucleoplasm pattern of BrUTP incorporation, not all SNF2H and BRG-1 foci of the two pronuclei (Fig. 1 e). contained TIF1α. Thus, sites of accumulation of TIF1α are also The time when we observed TIF1α translocation into the enriched with chromatin remodelers in the late zygote stage. pronuclei coincides with the time when chromatin remodelers and transcription machinery factors, such as Brahma-related RNAi or injection of antibodies against gene 1 (BRG-1; SMARCA4), Brahma (BRM; SMARCA2), TIF1 compromises early development and high mobility group box 1 (HMGB-1), translocate into the We next wished to assess the function of TIF1α at the begin- pronuclei (Bellier et al., 1997; Legouy et al., 1998; Beaujean ning of development of the mouse embryo. To this end, we used et al., 2000). This is also associated with the appearance of the two methods: RNAi and injection of antibodies.
Recommended publications
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Trim24 Targets Endogenous P53 for Degradation
    Trim24 targets endogenous p53 for degradation Kendra Alltona,b,1, Abhinav K. Jaina,b,1, Hans-Martin Herza, Wen-Wei Tsaia,b, Sung Yun Jungc, Jun Qinc, Andreas Bergmanna, Randy L. Johnsona,b, and Michelle Craig Bartona,b,2 aDepartment of Biochemistry and Molecular Biology, Program in Genes and Development, Graduate School of Biomedical Sciences and bCenter for Stem Cell and Developmental Biology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030; and cDepartment of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030 Edited by Carol L. Prives, Columbia University, New York, NY, and approved May 15, 2009 (received for review December 23, 2008) Numerous studies focus on the tumor suppressor p53 as a protector regulator of p53 suggests that potential therapeutic targets to of genomic stability, mediator of cell cycle arrest and apoptosis, restore p53 functions remain to be identified. and target of mutation in 50% of all human cancers. The vast majority of information on p53, its protein-interaction partners and Results and Discussion regulation, comes from studies of tumor-derived, cultured cells Creation of a Mouse and Stem Cell Model for p53 Analysis. To where p53 and its regulatory controls may be mutated or dysfunc- facilitate analysis of endogenous p53 in normal cells, we per- tional. To address regulation of endogenous p53 in normal cells, formed gene targeting to create mouse embryonic stem (ES) we created a mouse and stem cell model by knock-in (KI) of a cells and mice (12), which express endogenously regulated p53 tandem-affinity-purification (TAP) epitope at the endogenous protein fused with a C-terminal TAP tag (p53-TAPKI, Fig.
    [Show full text]
  • Trim24-Regulated Estrogen Response Is Dependent on Specific Histone Modifications in Breast Cancer Cells
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2012 TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS Teresa T. Yiu Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry Commons, Cancer Biology Commons, Medicine and Health Sciences Commons, and the Molecular Biology Commons Recommended Citation Yiu, Teresa T., "TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE MODIFICATIONS IN BREAST CANCER CELLS" (2012). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 313. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/313 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. TRIM24-REGULATED ESTROGEN RESPONSE IS DEPENDENT ON SPECIFIC HISTONE
    [Show full text]
  • Zebrafish Bloodthirsty: Developmental Expression and Identification of the Mammalian Ortholog
    1 Zebrafish bloodthirsty: Developmental Expression and Identification of the Mammalian Ortholog A thesis presented by Mo Hu to The Department of Biology In partial fulfillment of the requirements for degree of Master of Science in the field of Biology Northeastern University Boston, Massachusetts December, 2011 2 Zebrafish bloodthirsty: Developmental Expression and Identification of the Mammalian Ortholog A thesis presented by Mo Hu ABSTRACT OF THESIS Submited in partial fulfillment of the requirements for the degree of Master of Science in Biology in the Graduate School of Northeastern University December, 2011 3 Abstract Blood disorders, such as anemias, are serious diseases in humans. Because the hematopoietic program is highly conserved among vertebrates, we are using fish models to isolate novel erythropoietic genes and to elucidate the functions of the encoded proteins. In this thesis, I describe experiments to examine the developmental expression patterns of the novel zebrafish gene, bloodthirsty (bty), and to identify its probable mammalian ortholog. The novel gene bloodthirsty (bty) was discovered in a subtractive screen that isolated hematopoietic genes that were differentially expressed by the pronephric kidneys of the red-blood Antarctic rockcod, Notothenia coriiceps, and its white-blood relative, the icefish Chaenocephalus aceratus. Zebrafish bty encodes a 532 residue protein (Bloodthirsty, Bty) that belongs to the TRIM (TRIpartite Motif) protein family. Bty contains an N-terminal RING finger, two B-boxes, a coiled-coil region and a C-terminal B30.2 domain. Suppression of translation of the bty mRNA by morpholino oligonucleotide (MO) treatment suggests that Bty is involved in regulation of the terminal steps of the erythropoietic program.
    [Show full text]
  • TRIM28 Protects CARM1 from Proteasome-Mediated Degradation to Prevent Colorectal Cancer Metastasis
    Science Bulletin 64 (2019) 986–997 Contents lists available at ScienceDirect Science Bulletin journal homepage: www.elsevier.com/locate/scib Article TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis ⇑ ⇑ Jinyuan Cui a,b,1, Jia Hu b,1, Zhilan Ye b, Yongli Fan b, Yuqin Li b, Guobin Wang a,b, , Lin Wang b, , ⇑ Zheng Wang a,b, a Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China b Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China article info abstract Article history: TRIM28 (Tripartite motif-containing protein 28), a member of TRIM family, is aberrantly expressed and Received 27 February 2019 reportedly has different functions in many types of human cancer. However, the biological roles of Received in revised form 3 May 2019 TRIM28 and related mechanism in colorectal cancer (CRC) remain unclear. Here, we showed that Accepted 5 May 2019 TRIM28 was downregulated in colorectal cancer compared with normal mucosa, especially at advanced Available online 25 May 2019 stages, and acted as an independent prognostic factor of favorable outcome. Functional studies demon- strated that TRIM28 restrained CRC migration and invasion in vitro and in vivo. Mechanistically, we Keywords: reported that CARM1 (co-activator-associated arginine methyltransferase1) was a critical player down- Colorectal cancer stream of TRIM28. TRIM28 interacted with CARM1, and protected CARM1 from proteasome-mediated Metastasis TRIM28 degradation through physical protein-protein interaction to suppress CRC metastasis. Further, TRIM28 CARM1 suppressed the migration and invasion of CRC cells through inhibiting WNT/b-catenin signaling in a 0 Ubiquitination CARM1-dependent manner, but independent of CARM1 s methyltransferase activity.
    [Show full text]
  • Dissecting the Interaction Between P53 and TRIM24
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2011 Dissecting the Interaction between p53 and TRIM24 Aundrietta D. Duncan Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biology Commons, Molecular Biology Commons, and the Other Biochemistry, Biophysics, and Structural Biology Commons Recommended Citation Duncan, Aundrietta D., "Dissecting the Interaction between p53 and TRIM24" (2011). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 168. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/168 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. Dissecting the Interaction between p53 and TRIM24 By Aundrietta DeVan Duncan, B.S. Approved: __________________________________ Michelle Barton, PhD, Supervisory Professor ___________________________________
    [Show full text]
  • Emerging RNA-Binding Roles in the TRIM Family of Ubiquitin Ligases
    Biol. Chem. 2019; 400(11): 1443–1464 Review Felix Preston Williams, Kevin Haubrich, Cecilia Perez-Borrajero and Janosch Hennig* Emerging RNA-binding roles in the TRIM family of ubiquitin ligases https://doi.org/10.1515/hsz-2019-0158 proteins (RBPs) often lead to diseases such as neurologi- Received February 13, 2019; accepted April 11, 2019; previously cal disorders and cancer (Cooper et al., 2009). In recent published online May 23, 2019 decades, systems biology and the ‘omics’ revolution have greatly advanced our understanding of the global post- Abstract: TRIM proteins constitute a large, diverse and transcriptional changes that occur during various biologi- ancient protein family which play a key role in processes cal processes, including cell development and immune including cellular differentiation, autophagy, apoptosis, responses (Ahmad and Lamond, 2014; Angerer et al., DNA repair, and tumour suppression. Mostly known and 2017). In addition, methodological advances in the RNA studied through the lens of their ubiquitination activity field have expanded the number of putative RBPs (Baltz as E3 ligases, it has recently emerged that many of these et al., 2012; Castello et al., 2012; Gerstberger et al., 2014; proteins are involved in direct RNA binding through their Dominguez et al., 2018; Hentze et al., 2018) and put a NHL or PRY/SPRY domains. We summarise the current spotlight on low-affinity and multivalent protein-RNA knowledge concerning the mechanism of RNA binding interactions at the core of many important regulatory by TRIM proteins and its biological role. We discuss how mechanisms (Jankowsky and Harris, 2015; Falkenberg RNA-binding relates to their previously described func- et al., 2017).
    [Show full text]
  • New Insights from the Complete TRIM Repertoire of Zebrafish and Pufferfish
    Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of zebrafish and pufferfish Pierre Boudinot, Lieke M van der Aa, Luc Jouneau, Louis Du Pasquier, Pierre Pontarotti, Valérie Briolat, Abdenour Benmansour, Jean-Pierre Levraud To cite this version: Pierre Boudinot, Lieke M van der Aa, Luc Jouneau, Louis Du Pasquier, Pierre Pontarotti, et al.. Origin and evolution of TRIM proteins: new insights from the complete TRIM repertoire of ze- brafish and pufferfish. PLoS ONE, Public Library of Science, 2011, 6 (7), pp.e22022. 10.1371/jour- nal.pone.0022022. hal-00831143 HAL Id: hal-00831143 https://hal.archives-ouvertes.fr/hal-00831143 Submitted on 1 Oct 2018 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License Origin and Evolution of TRIM Proteins: New Insights from the Complete TRIM Repertoire of Zebrafish and Pufferfish Pierre Boudinot1*, Lieke M. van der Aa1,2, Luc Jouneau1, Louis Du Pasquier3, Pierre Pontarotti4, Vale´rie Briolat5,6, Abdenour Benmansour1,
    [Show full text]
  • Lysine Methylation of HIV-1 Tat Regulates Transcriptional Activity Of
    Retrovirology BioMed Central Research Open Access Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR Rachel Van Duyne1, Rebecca Easley1, Weilin Wu1, Reem Berro1, Caitlin Pedati1, Zachary Klase1, Kylene Kehn-Hall1, Elizabeth K Flynn2, David E Symer3 and Fatah Kashanchi*1,4 Address: 1The George Washington University Medical Center, Department of Biochemistry and Molecular Biology, Washington, DC 20037, USA, 2Basic Research Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA, 3Basic Research Laboratory, and Laboratory of Biochemistry and Molecular Biology, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA and 4W.M. Keck Institute for Proteomics Technology and Applications, Washington, DC 20037, USA Email: Rachel Van Duyne - [email protected]; Rebecca Easley - [email protected]; Weilin Wu - [email protected]; Reem Berro - [email protected]; Caitlin Pedati - [email protected]; Zachary Klase - [email protected]; Kylene Kehn- Hall - [email protected]; Elizabeth K Flynn - [email protected]; David E Symer - [email protected]; Fatah Kashanchi* - [email protected] * Corresponding author Published: 22 May 2008 Received: 3 January 2008 Accepted: 22 May 2008 Retrovirology 2008, 5:40 doi:10.1186/1742-4690-5-40 This article is available from: http://www.retrovirology.com/content/5/1/40 © 2008 Van Duyne et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The rate of transcription of the HIV-1 viral genome is mediated by the interaction of the viral protein Tat with the LTR and other transcriptional machinery.
    [Show full text]
  • A Manually Curated Network of the PML Nuclear Body Interactome
    Int. J. Biol. Sci. 2010, 6 51 International Journal of Biological Sciences 2010; 6(1):51-67 © Ivyspring International Publisher. All rights reserved Review A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics Ellen Van Damme1, Kris Laukens2, Thanh Hai Dang2, Xaveer Van Ostade1 1. Laboratory of Protein Chemistry, Proteomics and Signal Transduction, Department of Biomedical Sciences, University of Antwerp (Campus Drie Eiken), Universiteitsplein 1 – Building T, 2610 Wilrijk, Belgium. 2. Intelligent Systems Laboratory (ISLab) Department of Mathematics and Computer Science, University of Antwerp (Campus Middelheim), Middelheimlaan 1 – Building G, 2020 Antwerp, Belgium Correspondence to: Prof. Dr. Xaveer Van Ostade, [email protected], tel: 0032 (0)3 365 23 19 Received: 2009.10.20; Accepted: 2010.01.09; Published: 2010.01.12 Abstract Promyelocytic Leukaemia Protein nuclear bodies (PML-NBs) are dynamic nuclear protein aggregates. To gain insight in PML-NB function, reductionist and high throughput techniques have been employed to identify PML-NB proteins. Here we present a manually curated network of the PML-NB interactome based on extensive literature review including data- base information. By compiling ‘the PML-ome’, we highlighted the presence of interactors in the Small Ubiquitin Like Modifier (SUMO) conjugation pathway. Additionally, we show an enrichment of SUMOylatable proteins in the PML-NBs through an in-house prediction algo- rithm. Therefore, based on the PML network, we hypothesize that PML-NBs may function as a nuclear SUMOylation hotspot. Key words: PML-NB, SUMOylation, Cytoscape, protein-protein interaction, network Introduction Nuclear domain 10 (also called Kremer bodies cross-brace conformation.
    [Show full text]
  • Functional Characterization of TRIM24 and TRIM32 Proteins in the Heart Through Their Interaction with Dysbindin
    Aus der Klinik für Innere Medizin III im Universitätsklinikum Schleswig-Holstein, Campus Kiel an der Christian-Albrechts-Universität zu Kiel Direktor: Prof. Dr. Norbert Frey Functional characterization of TRIM24 and TRIM32 proteins in the heart through their interaction with Dysbindin Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Christian-Albrechts-Universität zu Kiel Vorgelegt von Ankush Borlepawar Kiel, 2019 First Examiner: Prof. Dr. Dennis Schade Second Examiner: Prof. Dr. Norbert Frey Date of the oral examination: 05.11.2019 2 Declaration: I hereby declare that, apart from the supervisor’s guidance the content and design of the current thesis is all of my own work. This doctoral thesis has never been submitted either partially or wholly as part of a doctoral degree to another examining body and has never been published nor has been submitted for publication. This thesis has been prepared in accordance to the Rules of Good Scientific Practice of the German Research Foundation. No academic degree has ever been withdrawn from me. Kiel, (Date) Doctoral candidate’s signature 3 Preface The work presented in this doctoral thesis has been performed under supervision of Prof. Dr. Norbert Frey in the Institute of Molecular Cardiology. The experimental work and its dissertation were conducted from August 2015 to November 2019. Various results arising from this doctoral thesis work have been published in renowned scientific journals, which also have been enlisted below. 4 1 Index 2 Summary
    [Show full text]
  • Gene Repression by KRAB Zinc Finger Proteins
    MECHANISMS OF TRANSCRIPTIONAL REGULATION: GENE REPRESSION BY KRAB ZINC FINGER PROTEINS AND GENE INDUCTION BY ESTROGEN RECEPTOR beta by SMITHA P. SRIPATHY Submitted in partial fulfillment of the requirements for a degree in Doctor of Philosophy. Dissertation advisors: David C. Schultz and Monica M. Montano Department of Pharmacology CASE WESTERN RESERVE UNIVERSITY January 2009 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of Smitha P. Sripathy for the Pharmacology degree *. (signed) Ruth A. Keri (chair of the committee) John J. Mieyal David Samols Monica M. Montano (date) 07/15/08 *We also certify that written approval has been obtained for any proprietary material contained therein. i Table of Contents List of figures and tables iii Acknowledgement viii List of abbreviations 1 Abstract 3 Chapter I Transcriptional regulation: An overview 6 Gene repression by KRAB zinc finger proteins Chapter II Introduction, review of literature and 17 statement of purpose Chapter III Mechanism of transcriptional repression of 35 KRAB zfps Chapter IV Summary and future directions 117 Gene induction by estrogen receptor beta Chapter V Introduction, review of literature and 134 statement of purpose Chapter VI Mechanism of transcriptional induction of 159 EpRE-genes by ERβ Chapter VII Summary and future directions 201 Bibliography 211 ii List of Tables and Figures Figure I-1 Hox gene clusters regulate head-tail morphology 9 in humans Table I-1 A minimal classification of transcriptional 11 coregulators Figure II-1 Representation of a complex between DNA and 19 the ZIF268 protein, containing 3 zinc finger motifs. Figure II-2 Sequence alignment of the KRAB domain from 22 different KRAB–ZFPs Figure II-3 Schematic representation of the TIF1 protein 26 family Figure III-1 KAP1 is required for KRAB-mediated repression 75 Figure III-2 Stable depletion of KAP1 in HEK293 cells.
    [Show full text]